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Abstract: 
 
Background: As part of our contribution to the growing pool of knowledge on the prevention and control of the 
COVID-19 pandemic, this study describes the demographic features of patients with COVID-19 hospitalized at 
Infectious Disease Center (IDC), Olodo, Ibadan, Oyo State, Nigeria.                        
Methodology: This was a descriptive cross-sectional study of COVID-19 patients whose data were collected 
during admission between April 27, 2020 and June 20, 2020. SARS-CoV-2 infection was diagnosed on 
nasopharyngeal specimen using a real-time reverse transcription–polymerase chain reaction (rRT-PCR) assay. 
Data were analysed using the Statistical Package for Social Sciences (SPSS Inc., USA) version 20.0                     
Results: Among 131 patients, 58% were between age 18 and 35 years, 48.1% were employees of private 
establishments, and 64.1% were males. High proportion (84.3%) of the patients spent less than 14 days on 
admission. As at June 20, 2020, the overall COVID-19 mortality in the IDC was 0.0%.                               
Conclusion: This study concluded that COVID-19 was common among male Nigerians, those working in private 
establishments, and those aged 18-35 years. Future researches on COVID-19 in Nigeria must put gender and 
age into consideration. 
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Abstrait: 
Contexte: Dans le cadre de notre contribution au pool croissant de connaissances sur la prévention et le contrôle 
de la pandémie COVID-19, cette étude décrit les caractéristiques démographiques des patients atteints de COVID-
19 hospitalisés au Centre des maladies infectieuses (IDC), Olodo, Ibadan, État d'Oyo, Nigéria.   
Méthodologie: Il s'agissait d'une étude transversale descriptive de patients atteints de COVID-19 dont les 
données ont été collectées lors de l'admission entre le 27 avril 2020 et le 20 juin 2020. L'infection par le SRAS-
CoV-2 a été diagnostiquée sur un échantillon nasopharyngé à l'aide d'une transcription inverse en temps réel–
Test de réaction en chaîne par polymérase (rRT-PCR). Les données ont été analysées à l'aide du Statistical 
Package for Social Sciences (SPSS Inc., USA) version 20.0                       
Résultats: Parmi 131 patients, 58% avaient entre 18 et 35 ans, 48,1% étaient des employés d'établissements 
privés et 64,1% étaient des hommes. Une forte proportion (84,3%) des patients ont passé moins de 14 jours à 
l'admission. Au 20 juin 2020, la mortalité globale par COVID-19 dans l'IDC était de 0,0%.               
Conclusion: Cette étude a conclu que le COVID-19 était courant chez les hommes Nigérians, ceux travaillant 
dans des établissements privés et ceux âgés de 18 à 35 ans. Les futures recherches sur le COVID-19 au Nigéria 
doivent prendre en compte le sexe et l'âge. 
Mots clés: SRAS-COV2; COVID-19; âge; le sexe; occupation 
Introduction: 
 
 Coronavirus disease-2019 (COVID-19), 
caused by severe acute respiratory syndrome 
coronavirus-2 (SARS-COV2) is a viral disease 
that is of great global public health concern. 
Coronavirus (COV) is one of the major viral 
pathogens that primarily targets the human 
respiratory system. Person-to-person trans- 
mission of coronaviruses occurs primarily via 
direct contact or through droplet spread when 
an infected individual coughs or sneezes (1). 
The binding of the receptor-binding domain 
(RBD) of the virus spike proteins to the host 
angiotensin converting enzyme-2 (ACE2) 
cellular receptor, fuses SARS-COV-2 with the 
host cellular membrane (2,3) to initiate and 
establish the disease. Therefore, measures to 
reduce person-to-person transmission of 
SARS-COV-2 in COVID-19 needs to be imple- 
mented to control the current pandemic 
through primary protection particularly of the 
susceptible populations such as the elderly, 
children, health care providers, and people 
with underlying medical conditions (1). 
  The symptoms of COVID-19 appear 
after an incubation period of approximately 
5.2 days while the period from the onset of 
COVID-19 symptoms to death ranged from 6 
to 41 days with a median of 14 days, but this 
is highly dependent on the age of the patient 
and status of the patient's immune system 
(4). This period has been reported to be 
shorter among patients above 70 years of age 
compared to those under the age of 70 years 
(4). These findings underscore the need to 
have a good understanding of the demo- 
graphic profiles of COVID-19 patients in diffe- 
rent populations. 
 The chronology of coronavirus infec- 
tions in Nigeria as revealed by the Federal 
Ministry of Health was that the first confirmed 
case of COVID-19 in Lagos State, Nigeria was 
registered on the 27th of February 2020, 
although the outbreak in China began in 
January 2020 (5). On 21st March 2020, the 
first case of COVID-19 was confirmed in 
Ibadan, Oyo State, Nigeria which brought the 
tally of confirmed COVID-19 cases in Nigeria 
at that time to 23 (6). By the 30th of July 
2020, Oyo State had a total 2,713 laboratory 
confirmed cases, 1,451 cases on admission at 
various isolation homes or health outposts, 
1,259 cases had been discharged, and 27 
deaths recorded (case fatality rate of 0.99%). 
In Nigeria as a whole on the same date, there 
were 42,689 confirmed cases, 22,331 active, 
19,270 discharged, and 878 deaths (case fat-
ality rate of 2.05%) (7). 
 According to a previous study, social 
and economic factors were reported to have 
potential impact on infectious disease dyna- 
mics (8). Fang et al., (9) reported that medi- 
cal staff density had significant positive 
influence on occurrence of SARS infection in 
mainland China. School education and living 
conditions were associated with hospitali- 
zation during the 2009 H1N1 influenza pan-
demic (10). Through respiratory droplets as 
the major means of transmission of SARS-
COV-2, COVID-19 now spreads easily and 
sustainably in the Nigerian community (11, 




12), and previous studies have opined that 
socio-economic factors such as occupation 
might have impacts on the COVID-19 spread. 
 Symptomatic COVID-19 patients are 
usually managed in isolation centers where 
varied management modalities including sup- 
portive and definitive therapies are admini- 
stered. One of such centers in Oyo State is the 
Infectious Disease Center located in Olodo, 
Ibadan, Nigeria. This study describes the 
demographic characteristics of COVID-19 
patients treated at the center over a period of 
approximately two months.  
 
Materials and method: 
 
Study setting 
 The study was conducted in Ibadan, 
the capital city of Oyo State, Nigeria, located 
about 100 miles (160 km) from the Atlantic 
coast. It is one of the most populous cities in 
the country and the economic activities of 
Ibadan include agriculture, commerce, handi- 
crafts, manufacturing, and service industries. 
Ibadan is an important commercial centre 
having many markets.  
 
Study design, subjects and data collection 
 This was a descriptive cross-sectional 
study of a total of 131 patients with COVID-19 
treated at the Infection Disease Center (IDC), 
Olodo, Ibadan, who were enrolled into the 
study between April 27, 2020 and June 20, 
2020. The COVID-19 cases with clinical 
symptoms of dry cough, high fever, sore 
throat and/or shortness of breath, were 
confirmed by detection of SARS-COV2 nucleic 
acid using real-time reverse-transcriptase 
polymerase chain reaction (rt-PCR) assay on 
nasal and pharyngeal swab specimens follo- 
wing recommended guidelines (13). 
 Data were collected using pre-tested 
questionnaire which contains information on 
age, gender, pre-existing conditions, occu- 
pation and level of education. The date of 
admission was subtracted from the day of 
discharge to obtain the number of days on 
admission. Before the commencement of the 
study, the approval (UI/EC/20/0233) was 
obtained from the University of Ibadan/ 
University College Hospital (UI/UCH) Joint 
Ethics Review Committee. In addition, infor- 




 Data obtained were analysed using 
Statistical Package for Social Sciences (SPSS 
Inc., USA) version 20.0 and the descriptive 
analyses of data were presented as frequency 
and percentages.  
Results: 
 The demographic characteristics of the 
131 COVID-19 participants are shown in Table 
1. High frequencies of the participants were 
between the ages of 18 and 35 years (58%), 
were largely employees of private 
establishments (48.1%), and mostly males 
(64.1%). One patient each had hypertension, 
diabetes mellitus, sickle cell anaemia and 
stroke, as underlying medical conditions. A 
high percentage (84.3%) of the patients spent 
less than 14 days on admission, and mortality 
was 0.0% during the period of study. The 
number of patients admitted and discharged 
increased weekly till week 4 and 5 respectively 
in the center (Fig 1). 
 
Table 1: Demographic characteristics of COVID-19 patients in Infectious Disease Center (IDC), Olodo, Ibadan, Nigeria 
Characteristic variables Frequency (n=131) Percentage 
Age group (years)   
<18 years 4 3.1 
18-35 years 76 58.0 
36-55 years 36 27.5 
>55 years 15 11.5 
Gender   
Male 84 64.1 
Female 47 35.9 
Occupation   
Unemployed 20 15.3 
Self employed 28 21.4 
Private Companies 63 48.1 
Civil servant 20 15.3 
Days on admission of 96 discharged patients   
≤7 days 8 8.3 
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 SARS-CoV-2 belongs to RNA family of 
coronavirus causing severe respiratory disea- 
ses in humans (14). Epidemiological studies 
show that the SARS-CoV-2 is more conta- 
gious than SARS-CoV but its lethality is said to 
less than that of SARS or MERS (1,15-18). 
However, the mortality of COVID-19 outbreak 
is still relatively high and the pandemic is 
ongoing in several countries of the world. The 
World Health Organization (WHO) on March 
10, 2020 reported mortality rates for COVID-
19 of 3.88% in China, 5.05% in Italy, 4.03% 
in the United States, 0.75% in South Korea, 
3.81% in Iran, 2.73% in Spain, 2.14% in 
France, 1.75% in Japan, 0.93% in Britain, and 
0.18% in Germany (1,15-18). As at July 30, 
2020, Oyo State in southwest Nigeria had 
reported 27 COVID-19 related deaths out of 
2,713 laboratory confirmed cases (case fata- 
lity rate of 0.99%), and 1,259 discharges (19). 
On the same date, Nigeria recorded 878 
COVID-19 related deaths out of a total of 
42,689 confirmed cases (case fatality rate of 
2.05%), with 19,270 discharges.  
 The predominant age-group affected, 
according to the Nigeria Center for Disease 
Control (NCDC) data was 31 to 40 years, and 
in relation to gender distribution, males were 
more frequently infected than females. With 
the increasing number of confirmed cases in 
the country, the NCDC believed that in the 
absence of a vaccine, compliance with infec- 
tion prevention and control (IPC) measures 
remains the most effective intervention to 
control the COVID-19 pandemic (20). Also, 
many experts believed that SARS-CoV-2 may 
coexist with humans for a long time (15), 
therefore, special attention should be paid to 
potential COVID-19 infection risks (21). Trac- 
king the epidemiological attributes of COVID-
19 patients in each locality will hence be highly 
required.     
 In this study, a higher proportion of 
patients with COVID-19 were males within the 
active age of 18 and 35 years. This 
observation supports the report that the most 
affected age groups in Nigeria are those in 31 
to 40 years group (22). Sun et al., (23) also 
reported similar observation in a part of China. 
This observation could be due to high outdoor 
activities in males within this age group which 
could increase their risks of contracting the 
virus. Most people in this age group are either 
in schools, unemployed or engaged in 




available petty employment such as selling, 
driving commercial bicycle, tricycle or taxis. 
Thus, this group of people are prone to 
contacting SARS-COV-2 especially when they 
do not adhere to infection prevention and 
control measures.  
 Data from some countries showed 
similar numbers of COVID-19 cases in women 
and men, but an increased case fatality in men 
(24,25). In our study however, no death was 
recorded for either male or female COVID-19 
patients during the study period, but the 
infection rate was 64.1% in the males 
compared to 35.9% in the females. Genetics 
and sex hormone differences determine sus-
ceptibility and response to viral infections 
between males and females, which may be 
responsible for the gender differences in the 
incidence and severity of COVID-19 in our 
study and those of others (26). It has also 
been reported that exposure to influenza A 
viruses is often higher in males than females 
but fatality following exposure is reportedly 
higher in females (27). The adaptive immune 
responses to viral infections differ between 
males and females (28). In the studies by 
Boissier et al., (29), Xia et al., (30) and 
Melgert et al., (31), the number and activity of 
innate immune cells were reportedly higher in 
females than in males.   
 In this study, the frequency of COVID 
-19 was highest among patients working in 
private companies (48.1%), followed by the 
unemployed (21.4%). Most of the patients 
working in private companies are staffs who 
have to adhere strictly to the rule and 
regulations of the employers or face the threat 
of sack. In private companies, gain is 
maximised and staff are paid based on work 
done. The high frequency of the disease 
among the unemployed group may be due to 
the fact that they are freely mobile in search 
of means of livelihood. Moreover, this group 
have limited resources and may have no fund 
to purchase face masks and hand-sanitizers 
needed to comply with COVID-19 preventive 
measures. Some of the them may also have 
some degrees of immuno-compromise from 
poor or malnutrition.    
 Because economic activities are closely 
related to human behaviour (32,33), they 
have impacts on the COVID-19 morbidity and 
mortality (8), which as a result of competition 
for scarce resources, could facilitate SARS-
COV2 transmission via respiratory droplets 
and contacts. The transmission of COVID-19 
via droplets and fomites is greatly enhanced 
by close contact between infectors and 
infectees (34). Ecological, biological, and 
social factors greatly influence infectious 
diseases dynamics (35). Some social and eco 
-nomic factors that change human behaviour 
also  present  challenges  for  prevention  and  
control of infectious diseases (36), including 
COVID-19. The development of the tertiary 
industry and retail sales needs large number 
of proprietors and consumers. Areas with total 
retail sales of consumer goods per unit of the 
land area indicate that people prefer to 
purchase in the market in these areas. These 
influencing factors lead to the risk of the 
transmission of COVID-19 in the commercial 
activity as seen in our study which showed 
that private workers were more frequently 
infected.    
 The number of admissions increased 
from the beginning of our recruitment. This 
was due to a number of factors such as; 
increased community transmission, increased 
numbers of screening centers, initial stigma 
related to COVID-19 had largely been ignored 
by the populace which aided voluntary rep- 
orting to screening centers, massive educa- 
tion, and enlightenment of the populace with 
a clear message that COVID-19 was not a 
“death-sentence”. There was no case of 
COVID-19 re-infection in the center during the 
period of the study, while the number of 
discharged cases increased weekly. This 
observation may have been related to 
effective management, and non-fatal nature of 
SARS-COV-2 strain, which may be respon- 
sible for the mild nature of the COVID-19 
disease without complications, seen in most of 
the patients at the time of admission. These 
may also account for zero mortality rate of 
COVID-19 cases in the center during this 
period.     
 The COVID-19 symptoms have been 
reported to resolve after about 10 days (37). 
However, viral shedding may continue inspite 
of symptoms disappearance (37,38), and 
COVID-19 RNA viral shedding can persist for 
about 18 days in the nasopharynx or 19 days 
in the faeces (39). Mild and asymptomatic 
cases tend to shed the virus for 10 days (8–15 
days) after symptom resolution (40), with 
90% resolving after 10 days and nearly all 
cases resolving after 15 days (38). These 
observations were consistent with findings in 
our center where most of our patients stayed 
between 8 and 14 days on admission. How- 
ever, multi-centered studies will be required to 
have a better understanding of the dyna- mics 
of the COVID-19 pandemic with regards to 
demography, disease burdens (mortality and 
morbidity) and risk factors associated with 
different stages of COVID-19.   
Conclusion: 
 In conclusion, our study showed that 
COVID-19 was more frequent among male 
Nigerians, those working in private establish- 
ment and those in active age group (18-35 
years), thus providing ideal about the likely 




SARS-COV-2 reservoir populations to be 
targeted for control measures in the ongoing 
COVID-19 pandemic in Nigeria. Our findings 
also emphasised the impact of age, occu- 
pation and gender on the incidence or case 
fatality of COVID-19, thus tailoring treatment 
accordingly or giving the basis for further 
studies, which should put gender and age 
analyses into consideration. 
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